for so many people, cancer is detected too late.
we are changing that.
Landing Med has developed the world's first
fully automated pre-cancer detection system.
Join us in bringing cervical cancer screening
to communities around the world.
LANDING CLOUD SYSTEM
Automated cloud-based platform for remote cancer screening and diagnosis
The Landing Cyto System performs fully automated scanning and analysis.
Analysis is performed by an automated intelligence system that has been trained on a database of millions of samples. It classifies each cell, measures the amount of DNA in its nucleus, and determines whether the cell is normal or atypical.
Because diagnoses are based on dual Feulgen DNA and EA50 staining on the same slide which allows visualization and measurements of both qualitative and quantitative features, the Landing Cyto System offers an unparalleled level of standardization and quality control.
Around the world, there are too few pathologists per patient
With a cloud system, more patients can be screened
The cloud aids pathologists with the diagnosis
Most of the work can be automated, which reduces pathologists’ workload, increases throughput, and saves time.
Analysis by the cloud improves the accuracy of the results, especially for pathologists with less experience.
How the Landing Cloud System works
Disclaimer: Landing Med recognizes that the internet is a global communication medium. However, laws, regulatory requirements, and medical practices regarding medical devices vary from country to country. The information included here may not be appropriate for use universally. Product avalability is subject to local regulatory authority approval.
Landing Med holds Artificial Intelligence in Cervical Cancer Screening Innovation Forum in Toledo, Ohio
Toledo, Ohio, October 21, 2017. Landing Med held the "Artificial Intelligence in Cervical Cancer Screening Innovation Forum" in Toledo this past weekend. The forum's focus was on the world's leading innovative technology for cervical cancer screening developed by...
The world’s first use of artificial intelligence and cloud computing for cervical cancer screening began in Wuhan, China
Wuhan, July 10, 2017. During the 2017 Conference of Overseas Chinese, Pioneering and Developing China, Landing Med organized the “Artificial Intelligence Innovation and Development Forum” where the use of artificial intelligence and cloud computing for cervical cancer...
Dr. Xiaorong Sun, Chairman and CEO of Landing Med, was invited to give a talk at the Pioneering and Developing Pittsburgh Conference. The conference was hosted by the Overseas Chinese Affairs office of State Council and Foreign affairs (Overseas Chinese affairs office) of Hubei Province.